| Control | Intervention | Intervention effecta | |||||
---|---|---|---|---|---|---|---|---|
Baseline | 12Â months | 24Â months | Baseline | 12Â months | 24Â months | IRR (95% CI) | P-value | |
No. patients in the analysis | 501 | 501 | 501 | 514 | 514 | 514 | Â | Â |
Specialist services | 18,205 | 17,729 | 16,336 | 18,904 | 18,349 | 17,179 | 0.99 (0.89 to 1.09)b | 0.78 |
 Mean (SD) | 36.34 (37.23) | 35.39 (49.04) | 32.61 (35.82) | 36.78 (31.79) | 35.70 (35.59) | 33.42 (41.44) | 0.99 (0.91 to 1.09)c | 0.90 |
Pharmaceuticals | 26,790 | 26,780 | 26,613 | 27,449 | 27,294 | 27,124 | 1.00 (0.94 to 1.06)b | 0.78 |
 Mean (SD) | 53.47 (37.44) | 53.45 37.32 | 53.12 39.71 | 53.40 37.24 | 53.10 36.93 | 52.77 38.20 | 1.00 (0.95 to 1.04)c | 0.94 |